{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:40:26Z","timestamp":1790948426345,"version":"4.1.0"},"reference-count":54,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Gedeon Richter Nordics AB","award":["DK-2019-04"],"award-info":[{"award-number":["DK-2019-04"]}]},{"name":"Gedeon Richter Nordics AB","award":["DK-2022-03"],"award-info":[{"award-number":["DK-2022-03"]}]},{"name":"Gedeon Richter Nordics AB","award":["DK-2023-08"],"award-info":[{"award-number":["DK-2023-08"]}]},{"name":"Gedeon Richter Nordics AB","award":["DK-2023-06"],"award-info":[{"award-number":["DK-2023-06"]}]},{"name":"Gedeon Richter Nordics AB","award":["DK-2024-08"],"award-info":[{"award-number":["DK-2024-08"]}]},{"name":"Gangsted-Rasmussen Foundation","award":["A39784"],"award-info":[{"award-number":["A39784"]}]},{"name":"Copenhagen University Hospital\u2014Herlev"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>STUDY QUESTION<\/jats:title>\n                    <jats:p>Are maternal concentrations of pregnancy-associated plasma protein-A (PAPP-A) and insulin-like growth factor-1 (IGF-1) influenced by the frozen embryo transfer (FET) protocol in early pregnancy?<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SUMMARY ANSWER<\/jats:title>\n                    <jats:p>Maternal concentrations of PAPP-A and IGF-1 were significantly lower in programmed cycle (PC) FET compared to modified natural cycle (mNC) FET among ovulatory women and compared to gonadotrophin-stimulated cycle (gSC) FET in anovulatory women.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>WHAT IS KNOWN ALREADY<\/jats:title>\n                    <jats:p>PC-FET has been associated with increased risks of preeclampsia and other placenta-related complications, pointing to altered placental development. PAPP-A and IGF-1 are biochemical markers of early placental function, and reduced levels have been linked to preeclampsia and other adverse outcomes. These markers may therefore provide insight into the pathways underlying the distinct risk profile of PC-FET.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>STUDY DESIGN, SIZE, DURATION<\/jats:title>\n                    <jats:p>This is a secondary analysis from a randomized controlled trial investigating estradiol and progesterone concentrations in FET treatments. The trial was conducted at Copenhagen University Hospital\u2014Herlev, Denmark, from April 2021 to December 2024. Biochemical analyses for PAPP-A and IGF-1 were performed on stored biobank samples from the trial. The main analyses included women with ongoing pregnancies (n\u2009=\u2009116), while additional analyses of IGF-1 were conducted in all ovulatory women with available biobank samples (n\u2009=\u2009193).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>\n                    <jats:p>Eligible participants were women aged 18\u201340\u2009years with BMI \u226435\u2009kg\/m2 undergoing frozen-thawed autologous blastocyst transfer. Ovulatory women were randomized to mNC or PC, and anovulatory women to gSC or PC. Samples were collected at the following 7 timepoints throughout treatment: on the 2nd or 3rd day of menstrual bleeding, on the day of trigger\/endometrial thickness \u22657\u2009mm, on the day of embryo transfer and by gestational ages (GA) 4\u2009+\u20092, 6\u2009+\u20090, 8\u2009+\u20090, and 9\u2009+\u20096. Data on placental weight were collected at delivery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n                    <jats:p>The present analyses included women with ongoing pregnancies from the parent trial: 43 in the ovulatory mNC group, 42 in the ovulatory PC group, 16 in the anovulatory gSC group, and 15 in the anovulatory PC group. PC had substantially lower IGF-1 concentrations from treatment initiation through GA 8\u2009+\u20090 compared to both mNC and gSC. Ovulatory women treated with PC showed significantly lower PAPP-A concentrations during endometrial preparation (7.4 vs 8.7 mU\/l; adjusted P\u2009=\u20090.02), at embryo transfer (6.7 vs 8.8 mU\/l; adjusted P\u2009&amp;lt;\u20090.001), and GA 4\u2009+\u20092 (7.2 vs 8.5 mU\/l; adjusted P\u2009=\u20090.03) than women treated with mNC. Among anovulatory women, PAPP-A concentrations were also reduced during endometrial preparation (5.8 vs 9.1 mU\/l; adjusted P\u2009=\u20090.008) in PC compared to gSC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>LIMITATIONS, REASONS FOR CAUTION<\/jats:title>\n                    <jats:p>As this was a secondary analysis, no formal power calculation was made, and statistical power may therefore be limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>\n                    <jats:p>We provide evidence that PC-FET was followed by lower IGF-1 concentrations in early pregnancy and by time-dependent reductions in PAPP-A compared to mNC-FET and gSC-FET. These findings suggest alterations in early placental biology that may contribute to the adverse obstetric risk profile associated with PC-FET. Future studies should clarify whether these changes are related to the use of oral estradiol and whether alternative administration routes could modify this risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>STUDY FUNDING\/COMPETING INTEREST(S)<\/jats:title>\n                    <jats:p>The trial was funded by Gedeon Richter Nordics AB, including analysis of biobank samples (grant numbers DK-2019-04, DK-2022-03, DK-2023-08, DK-2023-06, DK-2024-08). The trial also received one grant from the Gangsted-Rasmussen Foundation (grant number A39784) and a grant was obtained from the local research board at Copenhagen University Hospital\u2014Herlev. The study was designed and planned independently, with no involvement from the funders in data analysis or interpretation of the results. N.F.M. has received funding for congress attendance from Gedeon Richter Nordics AB and Merck A\/S, unrelated to the present work. B.N. has received grants to the institution from Merck A\/S, Gedeon Richter Nordics AB, and Ferring Pharmaceuticals A\/S, along with personal fees from Ferring Pharmaceuticals A\/S, travel support from Gedeon Richter Nordics AB, and has participated in a data safety monitoring or advisory board for Ferring Pharmaceuticals A\/S, outside of this research. M.K. has received funding from Rigshospitalets Research Board outside of this research. L.R. has received a research grant from the Novo Nordisk Foundation outside of this research. P.F.S. has received grants from Merck A\/S, Gedeon Richter Nordics AB, and Ferring Pharmaceuticals A\/S, travel support from Ferring Pharmaceuticals A\/S, and personal fees from Novo Nordisk for webinars, outside of this study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>TRIAL REGISTRATION NUMBER<\/jats:title>\n                    <jats:p>2020-001218-39 in EudraCT.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/humrep\/deag044","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T19:01:46Z","timestamp":1774378906000},"page":"870-881","source":"Crossref","is-referenced-by-count":2,"title":["Early pregnancy concentrations of pregnancy-associated plasma protein-A (PAPP-A) and insulin-like growth factor-1 (IGF-1) following frozen embryo transfer: secondary analyses from a randomized controlled trial"],"prefix":"10.1093","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7104-5722","authenticated-orcid":false,"given":"Nina Freiesleben","family":"M\u00f8rch","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Copenhagen University Hospital\u2014Herlev , Herlev,","place":["Denmark"]},{"name":"Department of Clinical Medicine, University of Copenhagen , Copenhagen,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9744-4452","authenticated-orcid":false,"given":"Bugge","family":"N\u00f8hr","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Copenhagen University Hospital\u2014Herlev , Herlev,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3119-017X","authenticated-orcid":false,"given":"Mille","family":"Kirk","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, University of Copenhagen , Copenhagen,","place":["Denmark"]},{"name":"Department of Clinical Biochemistry, Copenhagen University Hospital\u2014Rigshospitalet , Glostrup,","place":["Denmark"]},{"name":"Translational Research Centre, Rigshospitalet , Glostrup,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9080-3389","authenticated-orcid":false,"given":"Line","family":"Rode","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, University of Copenhagen , Copenhagen,","place":["Denmark"]},{"name":"Department of Clinical Biochemistry, Copenhagen University Hospital\u2014Rigshospitalet , Glostrup,","place":["Denmark"]},{"name":"Translational Research Centre, Rigshospitalet , Glostrup,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8534-7868","authenticated-orcid":false,"given":"Pernille Fog","family":"Svendsen","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Copenhagen University Hospital\u2014Herlev , Herlev,","place":["Denmark"]},{"name":"Department of Clinical Medicine, University of Copenhagen , Copenhagen,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"key":"2026060307540246700_deag044-B1","doi-asserted-by":"crossref","first-page":"H1936","DOI":"10.1152\/ajpheart.00590.2011","article-title":"Suppression of trophoblast uterine spiral artery remodeling by estrogen during baboon pregnancy: impact on uterine and fetal blood flow dynamics","volume":"302","author":"Aberdeen","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2026060307540246700_deag044-B2","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.placenta.2005.04.005","article-title":"Suppression of extravillous trophoblast invasion of uterine spiral arteries by estrogen during early baboon pregnancy","volume":"27","author":"Albrecht","year":"2006","journal-title":"Placenta"},{"key":"2026060307540246700_deag044-B3","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/humrep\/dep046","article-title":"Pregnancies conceived using assisted reproductive technologies (ART) have low levels of pregnancy-associated plasma protein-A (PAPP-A) leading to a high rate of false-positive results in first trimester screening for Down syndrome","volume":"24","author":"Amor","year":"2009","journal-title":"Hum Reprod"},{"key":"2026060307540246700_deag044-B4","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/humrep\/deaf049","article-title":"International Committee for Monitoring Assisted Reproductive Technologies (ICMART): world report for cycles conducted in 2017\u20132018","volume":"40","author":"Baker","year":"2025","journal-title":"Hum Reprod"},{"key":"2026060307540246700_deag044-B5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.placenta.2025.02.016","article-title":"Risk of preeclampsia and other pregnancy complications in frozen single euploid embryo transfers after natural versus artificial endometrial preparation: a truncated randomized controlled trial","volume":"163","author":"Bellver","year":"2025","journal-title":"Placenta"},{"key":"2026060307540246700_deag044-B6","doi-asserted-by":"crossref","first-page":"l2381","DOI":"10.1136\/bmj.l2381","article-title":"Pre-eclampsia: pathophysiology and clinical implications","volume":"366","author":"Burton","year":"2019","journal-title":"BMJ"},{"key":"2026060307540246700_deag044-B7","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/pd.5052","article-title":"Nuchal translucency measurement, free \u03b2-hCG and PAPP-A concentrations in IVF\/ICSI pregnancies: systematic review and meta-analysis","volume":"37","author":"Cavoretto","year":"2017","journal-title":"Prenat Diagn"},{"key":"2026060307540246700_deag044-B8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1152\/ajpregu.00239.2012","article-title":"Corpus luteal contribution to maternal pregnancy physiology and outcomes in assisted reproductive technologies perspectives","volume":"304","author":"Conrad","year":"2013","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2026060307540246700_deag044-B9","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ajog.2021.08.018","article-title":"Potential role of the corpus luteum in maternal cardiovascular adaptation to pregnancy and preeclampsia risk","volume":"226","author":"Conrad","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"2026060307540246700_deag044-B10","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s10815-024-03042-8","article-title":"Pathologic maternal and neonatal outcomes associated with programmed embryo transfer: potential etiologies and strategies for prevention","volume":"41","author":"Conrad","year":"2024","journal-title":"J Assist Reprod Genet"},{"key":"2026060307540246700_deag044-B11","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1080\/00016340802056178","article-title":"Placenta weight in pre-eclampsia","volume":"87","author":"Dahlstr\u00f8m","year":"2008","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2026060307540246700_deag044-B12","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.ajog.2004.06.052","article-title":"First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (The FASTER Trial)","volume":"191","author":"Dugoff","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"2026060307540246700_deag044-B13","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s00404-025-07935-6","article-title":"Singleton term pregnancies resulting from frozen-thawed embryo transfer in hormone replacement cycles increase the risk of aberrant placentation, including velamentous umbilical cord insertion","volume":"311","author":"Furuya","year":"2025","journal-title":"Arch Gynecol Obstet"},{"key":"2026060307540246700_deag044-B14","first-page":"CD003414","article-title":"Cycle regimens for frozen-thawed embryo transfer","volume":"2017","author":"Ghobara","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2026060307540246700_deag044-B15","doi-asserted-by":"crossref","first-page":"126.e1","DOI":"10.1016\/j.ajog.2019.03.010","article-title":"Neonatal and maternal outcome after frozen embryo transfer: increased risks in programmed cycles","volume":"221","author":"Ginstr\u00f6m Ernstad","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"2026060307540246700_deag044-B16","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1093\/humrep\/det295","article-title":"Multivariate analysis identifies the estradiol level at ovulation triggering as an independent predictor of the first trimester pregnancy-associated plasma protein-A level in IVF\/ICSI pregnancies","volume":"28","author":"Giorgetti","year":"2013","journal-title":"Hum Reprod"},{"key":"2026060307540246700_deag044-B17","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0002-9378(97)70598-2","article-title":"Insulin-like growth factor binding protein-1 at the maternal-fetal interface and insulin-like growth factor-I, insulin-like growth factor-II, and insulin-like growth factor binding protein-1 in the circulation of women with severe preeclampsia","volume":"176","author":"Giudice","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"2026060307540246700_deag044-B18","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10815-021-02379-8","article-title":"Importance of IGF-I levels in IVF: potential relevance for growth hormone (GH) supplementation","volume":"39","author":"Gleicher","year":"2022","journal-title":"J Assist Reprod Genet"},{"key":"2026060307540246700_deag044-B19","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1080\/14647273.2022.2040749","article-title":"Expression of vascular endothelial growth factor A (VEGFA), placental growth factor (PlGF) and insulin-like growth factor 1 (IGF-1) in serum from women undergoing frozen embryo transfer","volume":"26","author":"Guo","year":"2023","journal-title":"Hum Fertil (Camb)"},{"key":"2026060307540246700_deag044-B20","first-page":"1828","article-title":"Preeclampsia is associated with low circulating levels of insulin-like growth factor I and 1,25-dihydroxyvitamin D in maternal and umbilical cord compartments","volume":"85","author":"Halhali","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2026060307540246700_deag044-B21","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1046\/j.1365-2265.1996.8610870.x","article-title":"Effects of oral and transdermal oestrogen replacement therapy on plasma levels of insulin-like growth factors and IGF binding proteins 1 and 3: a cross-over study","volume":"45","author":"Helle","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2026060307540246700_deag044-B22","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/humrep\/deae027","article-title":"Is large for gestational age in singletons born after frozen embryo transfer associated with freezing technique or endometrial preparation protocol? A longitudinal national French study","volume":"39","author":"Hesters","year":"2024","journal-title":"Hum Reprod"},{"key":"2026060307540246700_deag044-B23","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0140-6736(24)00756-6","article-title":"Livebirth rate after one frozen embryo transfer in ovulatory women starting with natural, modified natural, or artificial endometrial preparation in Viet Nam: an open-label randomised controlled trial","volume":"404","author":"Ho","year":"2024","journal-title":"Lancet"},{"key":"2026060307540246700_deag044-B24","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s10815-017-0996-1","article-title":"Low first-trimester PAPP-A in IVF (fresh and frozen-thawed) pregnancies, likely due to a biological cause","volume":"34","author":"Hunt","year":"2017","journal-title":"J Assist Reprod Genet"},{"key":"2026060307540246700_deag044-B25","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1093\/humrep\/deu223","article-title":"Controlled ovarian hyperstimulation leads to high progesterone and estradiol levels during early pregnancy","volume":"29","author":"J\u00e4rvel\u00e4","year":"2014","journal-title":"Hum Reprod"},{"key":"2026060307540246700_deag044-B26","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/uog.5332","article-title":"First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics","volume":"31","author":"Kagan","year":"2008","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2026060307540246700_deag044-B27","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/B978-0-12-800094-6.00005-4","article-title":"Pregnancy-associated plasma protein A (PAPP-A) and preeclampsia","volume":"63","author":"Kalousov\u00e1","year":"2014","journal-title":"Adv Clin Chem"},{"key":"2026060307540246700_deag044-B28","doi-asserted-by":"crossref","first-page":"R23","DOI":"10.1530\/JOE-21-0087","article-title":"The growth hormone-insulin-like growth factor axis in pregnancy","volume":"251","author":"Kaur","year":"2021","journal-title":"J Endocrinol"},{"key":"2026060307540246700_deag044-B29","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.3109\/00016349.2010.505639","article-title":"Biology of pregnancy-associated plasma protein-A in relation to prenatal diagnostics: an overview","volume":"89","author":"Kirkegaard","year":"2010","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2026060307540246700_deag044-B30","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-213X-2-5","article-title":"Mesenchymally-derived insulin-like growth factor 1 provides a paracrine stimulus for trophoblast migration","volume":"2","author":"Lacey","year":"2002","journal-title":"BMC Dev Biol"},{"key":"2026060307540246700_deag044-B31","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/jcmm.17403","article-title":"Insulin-like growth factor 1 ameliorates pre-eclampsia by inhibiting zinc finger E-box binding homeobox 1 by up-regulation of microRNA-183","volume":"27","author":"Lai","year":"2023","journal-title":"J Cell Mol Med"},{"key":"2026060307540246700_deag044-B32","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1210\/er.2003-0035","article-title":"Estrogen regulation of growth hormone action","volume":"25","author":"Leung","year":"2004","journal-title":"Endocr Rev"},{"key":"2026060307540246700_deag044-B33","doi-asserted-by":"crossref","first-page":"e1004630","DOI":"10.1371\/journal.pmed.1004630","article-title":"Natural cycle versus hormone replacement therapy as endometrial preparation in ovulatory women undergoing frozen-thawed embryo transfer: the compete open-label randomized controlled trial","volume":"22","author":"Liu","year":"2025","journal-title":"PLoS Med"},{"key":"2026060307540246700_deag044-B34","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.fertnstert.2010.07.1048","article-title":"In combined first-trimester Down syndrome screening, the false-positive rate is not higher in pregnancies conceived after assisted reproduction compared with spontaneous pregnancies","volume":"95","author":"Matilainen","year":"2011","journal-title":"Fertil Steril"},{"key":"2026060307540246700_deag044-B35","doi-asserted-by":"crossref","first-page":"e12592","DOI":"10.1002\/rmb2.12592","article-title":"Risk factors for non-previa placenta accreta spectrum in pregnancies conceived through frozen embryo transfer during a hormone replacement cycle in Japan","volume":"23","author":"Matsuo","year":"2024","journal-title":"Reprod Med Biol"},{"key":"2026060307540246700_deag044-B36","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1053\/plac.2001.0684","article-title":"Three-dimensional ultrasound measurement of the placental volume in early pregnancy: method and correlation with biochemical placenta parameters","volume":"22","author":"Metzenbauer","year":"2001","journal-title":"Placenta"},{"key":"2026060307540246700_deag044-B37","doi-asserted-by":"crossref","first-page":"e058468","DOI":"10.1136\/bmjopen-2021-058468","article-title":"Estradiol and progesterone levels in early pregnancy after natural, estradiol + progesterone or gonadotrophin stimulated frozen embryo transfer cycle: a randomised controlled trial protocol","volume":"12","author":"M\u00f8rch","year":"2022","journal-title":"BMJ Open"},{"key":"2026060307540246700_deag044-B38","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s10815-025-03735-8","article-title":"Thyroid function in early pregnancy following frozen embryo transfer: analysis from a randomized controlled trial","volume":"43","author":"M\u00f8rch","year":"2026","journal-title":"J Assist Reprod Genet"},{"key":"2026060307540246700_deag044-B39","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1093\/humrep\/deaf083","article-title":"Estradiol and progesterone levels in early pregnancy after modified natural, programmed, and gonadotrophin-stimulated frozen embryo transfer cycles: a randomized controlled trial","volume":"40","author":"M\u00f8rch","year":"2025","journal-title":"Hum Reprod"},{"key":"2026060307540246700_deag044-B40","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/pd.5001","article-title":"Association of serum PAPP-A levels in first trimester with small for gestational age and adverse pregnancy outcomes: systematic review and meta-analysis","volume":"37","author":"Morris","year":"2017","journal-title":"Prenat Diagn"},{"key":"2026060307540246700_deag044-B41","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.humpath.2015.04.007","article-title":"Morphologic characteristics of the placental basal plate in in vitro fertilization pregnancies: a possible association with the amount of bleeding in delivery","volume":"46","author":"Nakamura","year":"2015","journal-title":"Hum Pathol"},{"key":"2026060307540246700_deag044-B42","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s10815-023-02785-0","article-title":"Is artificial endometrial preparation more associated with early-onset or late-onset preeclampsia after frozen embryo transfer?","volume":"40","author":"Niu","year":"2023","journal-title":"J Assist Reprod Genet"},{"key":"2026060307540246700_deag044-B43","doi-asserted-by":"publisher","DOI":"10.1007\/s10528-025-11212-1","article-title":"IGF1 is reduced in pregnancies with preeclampsia and its influence on biological behavior of trophoblast cells","author":"Qin","year":"2025","journal-title":"Biochem Genet"},{"key":"2026060307540246700_deag044-B44","doi-asserted-by":"crossref","first-page":"356.e1","DOI":"10.1016\/j.ajog.2015.04.026","article-title":"Association of in vitro fertilization outcome with circulating insulin-like growth factor components prior to cycle initiation","volume":"213","author":"Ramer","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"2026060307540246700_deag044-B45","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.placenta.2013.12.008","article-title":"IFPA senior award lecture: making sense of pre-eclampsia \u2013 two placental causes of preeclampsia?","volume":"35","author":"Redman","year":"2014","journal-title":"Placenta"},{"key":"2026060307540246700_deag044-B46","doi-asserted-by":"crossref","first-page":"360.e1","DOI":"10.1016\/j.ajog.2019.09.047","article-title":"Placental pathology in live births conceived with in vitro fertilization after fresh and frozen embryo transfer","volume":"222","author":"Sacha","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"2026060307540246700_deag044-B47","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1093\/humrep\/dez079","article-title":"Endometrial preparation methods for frozen-thawed embryo transfer are associated with altered risks of hypertensive disorders of pregnancy, placenta accreta, and gestational diabetes mellitus","volume":"34","author":"Saito","year":"2019","journal-title":"Hum Reprod"},{"key":"2026060307540246700_deag044-B48","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1113\/JP273330","article-title":"Placental phenotype and the insulin-like growth factors: resource allocation to fetal growth","volume":"595","author":"Sferruzzi-Perri","year":"2017","journal-title":"J Physiol"},{"key":"2026060307540246700_deag044-B49","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1365-2265.2007.02783.x","article-title":"Effects of the route of oestrogen administration on IGF-1 and IGFBP-3 in healthy postmenopausal women: results from a randomized placebo-controlled study","volume":"66","author":"Sonnet","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2026060307540246700_deag044-B50","doi-asserted-by":"crossref","first-page":"2448502","DOI":"10.1080\/14767058.2024.2448502","article-title":"Pregnancy-associated plasma protein A (PAPP-A) as a first trimester serum biomarker for preeclampsia screening: a systematic review and meta-analysis","volume":"38","author":"Tzanaki","year":"2025","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2026060307540246700_deag044-B51","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1161\/HYPERTENSIONAHA.118.12043","article-title":"Increased preeclampsia risk and reduced aortic compliance with in vitro fertilization cycles in the absence of a corpus luteum","volume":"73","author":"Von Versen-Ho\u00ffnck","year":"2019","journal-title":"Hypertension"},{"key":"2026060307540246700_deag044-B52","doi-asserted-by":"crossref","first-page":"2352142","DOI":"10.1080\/09513590.2024.2352142","article-title":"Effect of estrogen exposure on pregnancy outcomes in artificial frozen-thawed embryo transfer cycles","volume":"40","author":"Wei","year":"2024","journal-title":"Gynecol Endocrinol"},{"key":"2026060307540246700_deag044-B53","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/humupd\/dmad011","article-title":"Obstetric and neonatal outcomes after natural versus artificial cycle frozen embryo transfer and the role of luteal phase support: a systematic review and meta-analysis","volume":"29","author":"Zaat","year":"2023","journal-title":"Hum Reprod Update"},{"key":"2026060307540246700_deag044-B54","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.fertnstert.2021.09.033","article-title":"The impact of different cycle regimens on birthweight of singletons in frozen-thawed embryo transfer cycles of ovulatory women","volume":"117","author":"Zhou","year":"2022","journal-title":"Fertil Steril"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/41\/6\/870\/67501575\/deag044.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/41\/6\/870\/67501575\/deag044.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T11:54:15Z","timestamp":1780487655000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/41\/6\/870\/8539881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":54,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,3,24]]},"published-print":{"date-parts":[[2026,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/deag044","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2026,3,24]]}}}